Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.32 |
| ▸ | SPIN1 | Q9Y657 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4460699 | 0.88 | KCNH2 (0.30) | — | |
| SCHEMBL11136773 | 0.78 | CA12 (0.41) | EHMT2 | |
| SCHEMBL25565744 | 0.74 | EHMT2 (0.33) | EHMT2SPIN1ACHE | |
| SCHEMBL3371290 | 0.73 | HNF4A (0.42) | EHMT2SPIN1ACHE | |
| SCHEMBL3370746 | 0.70 | RXRA (0.41) | — | |
| SCHEMBL11144587 | 0.70 | TNFSF11 (0.41) | ACHE | |
| SCHEMBL81753 | 0.70 | RXRA (0.41) | — | |
| SCHEMBL4464547 | 0.70 | FTO (0.39) | ACHE | |
| SCHEMBL13712358 | 0.70 | LMNA (0.33) | — | |
| SCHEMBL13668258 | 0.69 | RXRA (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230149562-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | TIBA BIOTECH LLC (US) | 2023-05-18 | — | — | US | disclosed |
| US-20230149562-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | TIBA BIOTECH LLC (US) | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230149562-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | POLN, TLR9, TSG101 | EHMT2 3340/4885SPIN1 4490/4885ACHE 4846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.